Lack of Major Involvement of Common CYP2C Gene Polymorphisms in the Risk of Developing Cross-Hypersensitivity to NSAIDs

Cross-hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs) is a relatively common, non-allergic, adverse drug event triggered by two or more chemically unrelated NSAIDs. Current evidence point to COX-1 inhibition as one of the main factors in its etiopathogenesis. Evidence also suggest...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yolanda Macías, Jesús M. García-Menaya, Manuel Martí, Concepción Cordobés, Raquel Jurado-Escobar, José A. Cornejo-García, María J. Torres, Natalia Blanca-López, Gabriela Canto, Miguel Blanca, José J. Laguna, Joan Bartra, Ana Rosado, Javier Fernández, Elena García-Martín, José A. G. Agúndez
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2021-09-01
coleção:	Frontiers in Pharmacology
Assuntos:	CYP2C8 CYP2C9 CYP2C19 NSAID polymorphisms hypersensitivity
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fphar.2021.648262/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!